<< Back to News

System Formulary Update
Cenobamate (Xcopri)

Situation:

Cenobamate (Xcopri) 50 mg and 100 mg tablets were approved for addition to the health system formulary at the System Pharmacy and Therapeutics Committee meeting.

Background:

The following medication was reviewed: cenobamate (Xcopri) 50 mg and 100 mg tablets

Assessment/Recommendations:

System P&T voted to include the following product from the UNC Health Medication Formulary with restriction to continuation of home therapy:

• Cenobamate (Xcopri) 50 mg and 100 mg tablets

Note: Stock of this formulary product may vary at individual entities 

Formulary/Epic Changes will Go-Live on Tuesday, November 14, 2023